Precision BioSciences (DTIL) Insider Trading & Ownership $4.69 +0.31 (+7.08%) Closing price 04:00 PM EasternExtended Trading$4.59 -0.10 (-2.17%) As of 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Precision BioSciences (NASDAQ:DTIL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.00%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$64.13KNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$315.26K Get DTIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Precision BioSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DTIL Insider Buying and Selling by Quarter Precision BioSciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/3/2025John Alexander KellyCFOSell14,827$4.26$63,163.02 6/25/2025Melinda BrownDirectorBuy1,682$4.14$6,963.48 3/25/2025Geno J GermanoDirectorBuy3,250$5.30$17,225.00 3/24/2025Michael AmorosoCEOSell964$5.56$5,359.84 3/4/2025J. Jefferson SmithInsiderSell154$4.91$756.14 1/22/2025J. Jefferson SmithInsiderSell10,287$4.79$49,274.73 1/21/2025Michael AmorosoCEOSell36,838$4.67$172,033.46 12/30/2024Geno J GermanoDirectorBuy3,605$4.49$16,186.45 12/27/2024John Alexander KellyCFOBuy2,113$4.75$10,036.75 12/26/2024Melinda BrownDirectorBuy3,016$4.55$13,722.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/4/2024Michael AmorosoCEOSell3,012$8.19$24,668.28 (Data available from 1/1/2013 forward) DTIL Insider Trading Activity - Frequently Asked Questions Who is on Precision BioSciences' Insider Roster? The list of insiders at Precision BioSciences includes Alan List, Dario Scimeca, Geno J Germano, J. Jefferson Smith, John Alexander Kelly, Melinda Brown, and Michael Amoroso. Learn more on insiders at DTIL. What percentage of Precision BioSciences stock is owned by insiders? 4.00% of Precision BioSciences stock is owned by insiders. Learn more on DTIL's insider holdings. Which Precision BioSciences insiders have been buying company stock? The following insiders have purchased DTIL shares in the last 24 months: Geno J Germano ($33,411.45), John Alexander Kelly ($10,036.75), and Melinda Brown ($20,686.28). How much insider buying is happening at Precision BioSciences? Insiders have purchased a total of 13,666 DTIL shares in the last 24 months for a total of $64,134.48 bought. Which Precision BioSciences insiders have been selling company stock? The following insiders have sold DTIL shares in the last 24 months: Alan List ($10,130.74), Dario Scimeca ($17,968.71), J. Jefferson Smith ($52,209.65), John Alexander Kelly ($63,163.02), and Michael Amoroso ($317,267.10). How much insider selling is happening at Precision BioSciences? Insiders have sold a total of 79,121 Precision BioSciences shares in the last 24 months for a total of $460,739.22 sold. Precision BioSciences Key ExecutivesMr. Michael Amoroso (Age 46)President, CEO & Director Compensation: $1.07M1 recent tradesMr. John Alexander Kelly R.Ph. (Age 57)CFO & Principal Accounting Officer Compensation: $660.91k1 recent tradesDr. Alan F. List M.D. (Age 69)Chief Medical Officer Compensation: $692.17kDr. Jefferson J. Smith Ph.D. (Age 51)Co-Founder & Chief Research Officer Mei BurrisDirector of Investor Relations & FinanceMr. Dario Scimeca (Age 49)General Counsel & Secretary Compensation: $576.43kMr. Bruce StevensVice President of Quality & ComplianceMaurissa MessierSenior Director of Corporate CommunicationsMs. Juli BlancheChief People OfficerMr. Garrett GincleyHead of Manufacturing More Insider Trading Tools from MarketBeat Related Companies Heron Therapeutics Insider Trades Ventyx Biosciences Insider Trades Neoleukin Therapeutics Insider Trades Entrada Therapeutics Insider Trades CytomX Therapeutics Insider Trades enGene Insider Trades Puma Biotechnology Insider Trades Editas Medicine Insider Trades ALT5 Sigma Insider Trades C4 Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried? This page (NASDAQ:DTIL) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.